Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia

[1] Berry SJ(1984)The development of human benign prostatic hyperplasia with age J Urol 132 474-479

[2] Coffey DS(2016)Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links Prostate Cancer Prostatic Dis 19 7-13

[3] Walsh PC(2011)The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation Eur Urol 60 106-117

[4] Ewing LJ(2016)Inflammatory mediators in the development and progression of benign prostatic hyperplasia Nat Rev Urol 13 613-626

[5] He Q(2013)Correlation between benign prostatic hyperplasia and inflammation Curr Opin Urol 23 5-10

[6] Wang Z(2013)The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH) BJU Int 112 432-441

[7] Liu G(2014)The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy Curr Urol Rep 15 463-1303

[8] Daneshgari F(1997)Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value J Urol 157 1301-175

[9] MacLennan GT(2003)Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis Eur Urol 43 164-1384

[10] Gupta S(2005)The impact of acute and chronic inflammation in baseline biopsy on the risk of clinical progression of BPH: results from the MTOPS study J Urol 173 346-622

[1] Berry SJ(1984)The development of human benign prostatic hyperplasia with age J Urol 132 474-479

[2] Coffey DS(2016)Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links Prostate Cancer Prostatic Dis 19 7-13

[3] Walsh PC(2011)The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation Eur Urol 60 106-117

[4] Ewing LJ(2016)Inflammatory mediators in the development and progression of benign prostatic hyperplasia Nat Rev Urol 13 613-626

[5] He Q(2013)Correlation between benign prostatic hyperplasia and inflammation Curr Opin Urol 23 5-10

[6] Wang Z(2013)The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH) BJU Int 112 432-441

[7] Liu G(2014)The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy Curr Urol Rep 15 463-1303

[8] Daneshgari F(1997)Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value J Urol 157 1301-175

[9] MacLennan GT(2003)Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis Eur Urol 43 164-1384

[10] Gupta S(2005)The impact of acute and chronic inflammation in baseline biopsy on the risk of clinical progression of BPH: results from the MTOPS study J Urol 173 346-622